A decade after millions of women went cold turkey on the hormone pills that controlled their hot flashes, mood swings and other menopausal symptoms, some doctors say the therapy is safe to try again. The once-feared hormone therapy is now offered in smaller doses and for a shorter time period, said Dr. Christopher Englert, director of obstetrics and gynecology at Holy Name Medical Center in Teaneck. "More and more women are coming back to it.
Lani Martin went through life "in a coma." The Wyckoff resident had no energy and couldn't focus. She was losing her hair and getting depressed. In her late 40s, Martin was not in menopause yet, but after doing some research, she thought her issues might be hormonal. Blood tests confirmed low hormone levels and she decided to try bioidentical hormone replacement therapy (BHRT). Bioidenticals have identical molecular structure to the hormones produced by the human body. They are derived from plants such as yams and soy. Synthetic hormones, like PremPro, Premarin and Pro-vera, are created from horse urine.
WASHINGTON - Women who are past menopause and healthy should not take hormone replacement therapy in hopes of warding off dementia, bone fractures or heart disease, says a new analysis by the government task force that weighs the risks and benefits of screening and other therapies aimed at preventing illness. The recommendation by the U.S. Preventive Services Task Force does not necessarily apply to women who take hormone replacement therapy to reduce menopausal symptoms such as hot flashes, night sweats and vaginal dryness. The balance of harms and benefits for that use is expected to be addressed in an imminent report by the federal government's Office of Health Quality Research.
With Pfizer and plaintiffs' lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: It's turning into one of the longest- running mass torts in U.S. history. I believe that this is now the longest-running MDL with no inventory settlements and no mass settlements in sight," said Zoe Littlepage, a partner at Littlepage Booth in Houston and lead plaintiffs' counsel in the federal multi-district litigation.
Don't let the scary - and flawed - headline-grabbing new study about hormone therapy and breast cancer come between you and the pills that are cooling your hot flashes, helping you sleep and lighting up your sex life again. Before you freak out, take a deep breath and consider three crucial facts that much of the media overlooked: * The study used unsafe (and we think outmoded) hormones. The Women's Health Initiative tracked women who took Prempro, a mix of conjugated equine estrogens (yup, from horses) and medroxyprogesterone acetate. This form of estrogen, by itself, seemed to slightly lower breast cancer risk in related WHI research. (You read that right: Estrogen alone turned down the risk.) But adding this type of progesterone canceled this apparent benefit and screwed up other thi...
LOS ANGELES - Mammogram rates fell among U.S. women in 2005, which puzzled public health officials because rates had been consistent for many years. A new study offers a possible explanation: The backlash against hormone therapy for menopausal symptoms led to the drop in mammograms. Hormone therapy was a popular strategy for post-menopausal women throughout the 1980s and '90s. The pills were used to ease menopausal symptoms and with the expectation that they might also help prevent some of the diseases of aging, such as heart disease and some types of cancer.
The conclusions were clear: Women who took hormone therapy drugs were at increased risk for breast cancer, heart disease, stroke and blood clots. The findings were so strong that researchers stopped a clinical trial in 2002, five years early, because it would have been unethical to continue giving the drugs to women.
Hormone replacement therapy, already linked to increases in breast cancer, heart disease and stroke, nearly doubles a woman's risk of dying from lung cancer, researchers reported Saturday in a finding that may be the final nail in the coffin for a therapy that is already in rapidly declining use. The findings "seriously question whether hormone-replacement therapy has any role in medicine today," wrote Dr. Apar Kishor Ganti of the University of Nebraska Medical Center in an editorial accompanying the online publication of the report in the medical journal Lancet.
Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms - balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death. The study represents one of 130 abstracts submitted to SNIS for consideration for presentation at what has become the premier scientific forum ...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other interesting searches:
Graham Wright | Johan Nyberg | title 18 pa | Flight Centre Ltd | Wynonna Judd | Sinistro | decreto ingiuntivo esecutivo | portable lg | opción compra venta | Quissac
